pSpCas9(BB)-2A-Neo Citations (3)

Originally described in: Used for expression of sgRNA in mammalian cells
Unpublished

---

Articles Citing pSpCas9(BB)-2A-Neo

Articles
Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy. Vornholz L, Isay SE, Kurgyis Z, Strobl DC, Loll P, Mosa MH, Luecken MD, Sterr M, Lickert H, Winter C, Greten FR, Farin HF, Theis FJ, Ruland J. Sci Adv. 2023 Mar 17;9(11):eadd8564. doi: 10.1126/sciadv.add8564. Epub 2023 Mar 15. PubMed
Recruitment of chromatin remodelers by XIST B-repeat region is variably dependent on HNRNPK. Navarro-Cobos MJ, Brown CJ. Hum Mol Genet. 2025 Feb 1;34(3):229-238. doi: 10.1093/hmg/ddae173. PubMed
Impact of somatic XIST deletions on ongoing XIST expression and inactive X silencing and heterochromatin. Bhangu KS, Yang C, Illing HJ, Brown CJ. Hum Mol Genet. 2025 Dec 4;34(24):2027-2041. doi: 10.1093/hmg/ddaf160. PubMed

If you have published an article using this material, please email us at to have your article added to this page.